Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer
NCT01848015 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2015-05-19
Summary
To assess the predictive value of circulating tumor cells (CTCs) for recurrence of advanced gastric cancer after radical resection.
To identify the relationship between the detection of circulation tumor cells and recurrence patterns of gastric cancer after radical resection.
Conditions
Interventions
- OTHER
-
detection of CTCs
Sponsors & Collaborators
-
Peking University
lead OTHER
Principal Investigators
-
Lin Shen, MD, PhD · Peking University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- China
Study Locations
More Related Trials
-
The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.
NCT02704299 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
PET-CT and Circulating Tumor Cells in Colorectal Cancer
NCT01163305 ·Status: COMPLETED
-
PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer
NCT07031011 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer
NCT06432075 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer
NCT01460641 ·Status: COMPLETED
-
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
NCT04287400 ·Status: RECRUITING
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
NCT01445327 ·Status: TERMINATED
-
Procalcitonin to Predict Infection After Gastrectomy for Gastric Cancer
NCT03780439 ·Status: COMPLETED
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING
-
Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer
NCT03615170 ·Status: UNKNOWN
-
ctDNA for Prediction of Relapse in Gastric Cancer
NCT02887612 ·Status: UNKNOWN
-
Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies
NCT06041815 ·Status: UNKNOWN
-
Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer
NCT01671891 ·Status: UNKNOWN
-
A Pilot Study of Neoadjuvant Chemotherapy Combined With Bevacizumab for Locally Advanced Rectal Cancer
NCT03245203 ·Status: UNKNOWN ·Phase: NA
-
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677 ·Status: RECRUITING
-
Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
NCT06647901 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
NCT06346093 ·Status: RECRUITING ·Phase: NA
-
Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
NCT04363983 ·Status: RECRUITING ·Phase: NA
-
In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors
NCT06185907 ·Status: COMPLETED
-
Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy
NCT05465512 ·Status: COMPLETED
-
Rectal Cancer CTC Trial
NCT07194616 ·Status: RECRUITING ·Phase: NA
-
D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer
NCT01836991 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
NCT06943807 ·Status: RECRUITING
-
Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients
NCT03564834 ·Status: UNKNOWN ·Phase: PHASE2